Navigation Links
ISPE Releases New Guidance for Standardizing Use of Booklet Labels in Global Clinical Trials
Date:4/3/2013

Tampa, Fla. USA (PRWEB) April 03, 2013

ISPE, a leading authority on best practices for the pharmaceutical industry, announced today that it has issued the industry’s first-ever guidance to help companies conducting clinical trials in multiple countries standardize their use of booklet labels. The Guide provides templates, guidelines and tools to make it easier for companies to use booklet labels consistently and effectively and justify their booklet label methods to international regulatory authorities.

“ISPE is pleased to introduce its first Guide to support harmonization of labeling requirements globally,” said ISPE President and CEO Nancy S. Berg. “Companies involved in clinical trials now have a resource that provides guidance on how to design and structure a booklet label and how to standardize the use and application of booklet labels for global clinical trials. By following the recommendations presented in the Guide, companies can feel confident that their booklet label strategy is supported by a scientific, risk-based methodology and patients are receiving accurate, complete instructions in their local language.”

The ISPE Good Practice Guide: Booklet Labels has been reviewed by MHRA officials, and their feedback has been incorporated into the Guide’s content. The Guide’s recommendations will help companies determine the gaps between their current booklet label procedures and best practices. It contains resources for training clinical trial personnel on proper booklet label use and templates that companies can put into practice immediately to help improve compliance and cost-effectiveness of their clinical trials.

The ISPE Good Practice Guide: Booklet Labels is available for purchase on the ISPE website.

About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit http://www.ISPE.org for more information.

Read the full story at http://www.prweb.com/releases/ispe/bookletlabels/prweb10598139.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GLM Displays Releases New & Improved Hop-Up Displays
2. eScience Labs Releases 2nd Edition Anatomy and Physiology Lab Kit
3. Manipulating the Brain to Eliminate Fear or Restore Memories – Rudy Mazzocchi Releases the 2nd Novel in The EQUITY Series entitled "EQUITY of FEAR"
4. Boca Bearings Releases Packaging Industry Bearings
5. Why Plastic Water Baths Prevent the Contamination of Samples - Revolutionary Science Releases a Brand New Poly ProBath Video
6. BioPharm Insight Releases its Catalyst Monitor for April 2013
7. SoundMindz TM Releases ‘Anti-Anxiety TM’ Mobile App - A Complete Stress Therapy Program
8. HCCS Releases New Social Media Online Training Course
9. Smith & Nephew releases new Modular Rail System in collaboration with Dr. Dror Paley
10. Organic-Based Bed Bug Spray Kills Bed Bugs in Seconds, My Cleaning Products Releases Samples of the Product
11. Infinata’s BioPharm Insight Releases Licensing League Tables Report for 4Q12 and YE12
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... United States multicenter, prospective clinical study that demonstrates the accuracy of the ... of identifying clinically significant acute bacterial and viral respiratory tract infections by ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
(Date:3/30/2017)... HONG KONG , March 30, 2017 ... developed a system for three-dimensional (3D) fingerprint identification by adopting ground ... technology into a new realm of speed and accuracy for use ... applications at an affordable cost. ... ...
Breaking Biology News(10 mins):